 | • レポートコード：QYR9ST01418 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のコンジュゲートワクチン市場について調査・分析し、以下の構成でお届け致します。コンジュゲートワクチンの種類別には、一価コンジュゲートワクチン、多価コンジュゲートワクチンに、用途別には、小児科、成人に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別コンジュゲートワクチン売上データ ・地域別コンジュゲートワクチン市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別コンジュゲートワクチン市場規模：一価コンジュゲートワクチン、多価コンジュゲートワクチン ・用途別コンジュゲートワクチン市場規模：小児科、成人 ・主要メーカーの企業情報：Novartis、Neuron Biotech、Serum Institute of India、Pfizer、Sanofi Pasteur、Bharat Biotech、Biological、GlaxoSmithKline、Merck、CSL ・コンジュゲートワクチンの市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein.This protein has a key role in enhancing the immunogenic property of the polysaccharide. These vaccines are mainly used to immunize infants and children against invasive disease caused by Hib bacteria, H. influenzae, Streptococcus pneumoniae, and Neisseria meningitidis.
The increase in use of conjugate vaccines for adults, rise in number of regulatory approvals for conjugate vaccines, growth in prevalence of diseases caused by microorganisms such as Streptococcus pneumoniae and Neisseria meningitidis, and technological advancements majorly drive the growth of the market. In contrast, low accessibility to vaccines in remote areas and complex production procedure of conjugate vaccine restraint the market growth.
The global Conjugate Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Conjugate Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of Conjugate Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Conjugate Vaccines in these regions.
This research report categorizes the global Conjugate Vaccines market by top players/brands, region, type and end user. This report also studies the global Conjugate Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis
Neuron Biotech
Serum Institute of India
Pfizer
Sanofi Pasteur
Bharat Biotech
Biological
GlaxoSmithKline
Merck
CSL
Market size by Product
By type
Monovalent Conjugate Vaccines
Multivalent Conjugate Vaccines
By disease indication
Pneumococcal
Influenza
Diphtheria Tetanus and Pertussis (DTP)
Meningococcal
Others
By pathogen type
Bacterial Conjugate Vaccine
Viral Conjugate Vaccine
Combination (Viral and Bacterial) Conjugate Vaccine
Market size by End User
Pediatrics
Adults
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Conjugate Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Conjugate Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Conjugate Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Conjugate Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Conjugate Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Conjugate Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Conjugate Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Conjugate Vaccines Market Size Growth Rate by Product
1.4.2 Monovalent Conjugate Vaccines
1.4.3 Multivalent Conjugate Vaccines
1.5 Market by End User
1.5.1 Global Conjugate Vaccines Market Size Growth Rate by End User
1.5.2 Pediatrics
1.5.3 Adults
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Conjugate Vaccines Market Size
2.1.1 Global Conjugate Vaccines Revenue 2014-2025
2.1.2 Global Conjugate Vaccines Sales 2014-2025
2.2 Conjugate Vaccines Growth Rate by Regions
2.2.1 Global Conjugate Vaccines Sales by Regions
2.2.2 Global Conjugate Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Conjugate Vaccines Sales by Manufacturers
3.1.1 Conjugate Vaccines Sales by Manufacturers
3.1.2 Conjugate Vaccines Sales Market Share by Manufacturers
3.1.3 Global Conjugate Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Conjugate Vaccines Revenue by Manufacturers
3.2.1 Conjugate Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Conjugate Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 Conjugate Vaccines Price by Manufacturers
3.4 Conjugate Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Conjugate Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Conjugate Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Conjugate Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Conjugate Vaccines Sales by Product
4.2 Global Conjugate Vaccines Revenue by Product
4.3 Conjugate Vaccines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Conjugate Vaccines Breakdown Data by End User
6 North America
6.1 North America Conjugate Vaccines by Countries
6.1.1 North America Conjugate Vaccines Sales by Countries
6.1.2 North America Conjugate Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Conjugate Vaccines by Product
6.3 North America Conjugate Vaccines by End User
7 Europe
7.1 Europe Conjugate Vaccines by Countries
7.1.1 Europe Conjugate Vaccines Sales by Countries
7.1.2 Europe Conjugate Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Conjugate Vaccines by Product
7.3 Europe Conjugate Vaccines by End User
8 Asia Pacific
8.1 Asia Pacific Conjugate Vaccines by Countries
8.1.1 Asia Pacific Conjugate Vaccines Sales by Countries
8.1.2 Asia Pacific Conjugate Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Conjugate Vaccines by Product
8.3 Asia Pacific Conjugate Vaccines by End User
9 Central & South America
9.1 Central & South America Conjugate Vaccines by Countries
9.1.1 Central & South America Conjugate Vaccines Sales by Countries
9.1.2 Central & South America Conjugate Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Conjugate Vaccines by Product
9.3 Central & South America Conjugate Vaccines by End User
10 Middle East and Africa
10.1 Middle East and Africa Conjugate Vaccines by Countries
10.1.1 Middle East and Africa Conjugate Vaccines Sales by Countries
10.1.2 Middle East and Africa Conjugate Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Conjugate Vaccines by Product
10.3 Middle East and Africa Conjugate Vaccines by End User
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Business Overview
11.1.3 Novartis Conjugate Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Novartis Conjugate Vaccines Products Offered
11.1.5 Novartis Recent Development
11.2 Neuron Biotech
11.2.1 Neuron Biotech Company Details
11.2.2 Company Business Overview
11.2.3 Neuron Biotech Conjugate Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Neuron Biotech Conjugate Vaccines Products Offered
11.2.5 Neuron Biotech Recent Development
11.3 Serum Institute of India
11.3.1 Serum Institute of India Company Details
11.3.2 Company Business Overview
11.3.3 Serum Institute of India Conjugate Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Serum Institute of India Conjugate Vaccines Products Offered
11.3.5 Serum Institute of India Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Business Overview
11.4.3 Pfizer Conjugate Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Pfizer Conjugate Vaccines Products Offered
11.4.5 Pfizer Recent Development
11.5 Sanofi Pasteur
11.5.1 Sanofi Pasteur Company Details
11.5.2 Company Business Overview
11.5.3 Sanofi Pasteur Conjugate Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Sanofi Pasteur Conjugate Vaccines Products Offered
11.5.5 Sanofi Pasteur Recent Development
11.6 Bharat Biotech
11.6.1 Bharat Biotech Company Details
11.6.2 Company Business Overview
11.6.3 Bharat Biotech Conjugate Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Bharat Biotech Conjugate Vaccines Products Offered
11.6.5 Bharat Biotech Recent Development
11.7 Biological
11.7.1 Biological Company Details
11.7.2 Company Business Overview
11.7.3 Biological Conjugate Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Biological Conjugate Vaccines Products Offered
11.7.5 Biological Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 Company Business Overview
11.8.3 GlaxoSmithKline Conjugate Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 GlaxoSmithKline Conjugate Vaccines Products Offered
11.8.5 GlaxoSmithKline Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Company Business Overview
11.9.3 Merck Conjugate Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Merck Conjugate Vaccines Products Offered
11.9.5 Merck Recent Development
11.10 CSL
11.10.1 CSL Company Details
11.10.2 Company Business Overview
11.10.3 CSL Conjugate Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.10.4 CSL Conjugate Vaccines Products Offered
11.10.5 CSL Recent Development
12 Future Forecast
12.1 Conjugate Vaccines Market Forecast by Regions
12.1.1 Global Conjugate Vaccines Sales Forecast by Regions 2019-2025
12.1.2 Global Conjugate Vaccines Revenue Forecast by Regions 2019-2025
12.2 Conjugate Vaccines Market Forecast by Product
12.2.1 Global Conjugate Vaccines Sales Forecast by Product 2019-2025
12.2.2 Global Conjugate Vaccines Revenue Forecast by Product 2019-2025
12.3 Conjugate Vaccines Market Forecast by End User
12.4 North America Conjugate Vaccines Forecast
12.5 Europe Conjugate Vaccines Forecast
12.6 Asia Pacific Conjugate Vaccines Forecast
12.7 Central & South America Conjugate Vaccines Forecast
12.8 Middle East and Africa Conjugate Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Conjugate Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Conjugate Vaccines Product Picture
Table Conjugate Vaccines Market Segments
Table Key Manufacturers Conjugate Vaccines Covered
Table Global Conjugate Vaccines Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)
Figure Global Conjugate Vaccines Sales Market Share by Product 2014-2025
Figure Monovalent Conjugate Vaccines Product Picture
Table Major Manufacturers of Monovalent Conjugate Vaccines
Figure Multivalent Conjugate Vaccines Product Picture
Table Major Manufacturers of Multivalent Conjugate Vaccines
Table Global Conjugate Vaccines Market Size Growth Rate by End User 2019-2025 (K Doses)
Figure Pediatrics
Figure Adults
Figure Conjugate Vaccines Report Years Considered
Figure Global Conjugate Vaccines Market Size 2014-2025 (Million US$)
Figure Global Conjugate Vaccines Sales 2014-2025 (K Doses)
Table Global Conjugate Vaccines Market Size by Regions 2014-2019 (K Doses) & (Million US$)
Table Global Conjugate Vaccines Sales by Regions 2014-2019 (K Doses)
Table Global Conjugate Vaccines Sales Market Share by Regions 2014-2019
Figure Global Conjugate Vaccines Sales Market Share by Regions 2014-2019
Figure 2018 Global Conjugate Vaccines Sales Market Share by Regions
Table Global Conjugate Vaccines Revenue by Regions 2014-2019 (Million US$)
Table Global Conjugate Vaccines Revenue Market Share by Regions 2014-2019
Figure Global Conjugate Vaccines Revenue Market Share by Regions 2014-2019
Figure 2018 Global Conjugate Vaccines Revenue Market Share by Regions
Table Global Conjugate Vaccines Sales by Manufacturers (2014-2019) (K Doses)
Table Global Conjugate Vaccines Sales Share by Manufacturers (2014-2019)
Figure Global Conjugate Vaccines Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Conjugate Vaccines Revenue by Manufacturers (2014-2019) (Million USD)
Table Conjugate Vaccines Revenue Share by Manufacturers (2014-2019)
Figure Conjugate Vaccines Value Share by Manufacturers in 2018
Table Key Manufacturers Conjugate Vaccines Price (2014-2019) (USD/Doses)
Table Conjugate Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Conjugate Vaccines Product Type
Table Date of International Manufacturers Enter into Conjugate Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Conjugate Vaccines Sales by Product (2014-2019) (K Doses)
Table Global Conjugate Vaccines Sales Share by Product (2014-2019)
Figure Global Conjugate Vaccines Sales Market Share by Product (2014-2019)
Figure Global Conjugate Vaccines Sales Market Share by Product in 2018
Table Global Conjugate Vaccines Revenue by Product (2014-2019) (Million US$)
Table Global Conjugate Vaccines Revenue Share by Product (2014-2019)
Figure Global Conjugate Vaccines Revenue Market Share by Product (2014-2019)
Figure Global Conjugate Vaccines Revenue Market Share by Product in 2018
Table Conjugate Vaccines Price by Product 2014-2019 (USD/Doses)
Table Global Conjugate Vaccines Sales by End User (2014-2019) (K Doses)
Table Global Conjugate Vaccines Sales Share by End User (2014-2019)
Figure Global Sales Conjugate Vaccines Market Share by End User (2014-2019)
Figure Global Sales Conjugate Vaccines Market Share by End User in 2018
Figure North America Conjugate Vaccines Sales Growth Rate 2014-2019 (K Doses)
Figure North America Conjugate Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table North America Conjugate Vaccines Sales by Countries (2014-2019) (K Doses)
Table North America Conjugate Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 North America Conjugate Vaccines Sales Market Share by Countries
Table North America Conjugate Vaccines Revenue by Countries (2014-2019) (Million US$)
Table North America Conjugate Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Conjugate Vaccines Revenue Market Share by Countries
Figure United States Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure United States Conjugate Vaccines Revenue Growth Rate (2014-2019) (K Doses)
Figure Canada Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Canada Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Mexico Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table North America Conjugate Vaccines Sales by Product (2014-2019) (K Doses)
Table North America Conjugate Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 North America Conjugate Vaccines Market Share by Product
Table North America Conjugate Vaccines Sales by End User (2014-2019) (K Doses)
Table North America Conjugate Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 North America Conjugate Vaccines Market Share by End User
Figure Europe Conjugate Vaccines Sales Growth Rate 2014-2019 (K Doses)
Figure Europe Conjugate Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Conjugate Vaccines Sales by Countries (2014-2019) (K Doses)
Table Europe Conjugate Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Conjugate Vaccines Sales Market Share by Countries
Table Europe Conjugate Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Europe Conjugate Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Conjugate Vaccines Revenue Market Share by Countries
Figure Germany Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Germany Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure France Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure France Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure UK Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Italy Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Russia Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Conjugate Vaccines Sales by Product (2014-2019) (K Doses)
Table Europe Conjugate Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Europe Conjugate Vaccines Market Share by Product
Table Europe Conjugate Vaccines Sales by End User (2014-2019) (K Doses)
Table Europe Conjugate Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Europe Conjugate Vaccines Market Share by End User
Figure Asia Pacific Conjugate Vaccines Sales Growth Rate 2014-2019 (K Doses)
Figure Asia Pacific Conjugate Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Conjugate Vaccines Sales by Countries (2014-2019) (K Doses)
Table Asia Pacific Conjugate Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Conjugate Vaccines Sales Market Share by Countries
Table Asia Pacific Conjugate Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Conjugate Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Conjugate Vaccines Revenue Market Share by Countries
Figure China Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure China Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Japan Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Korea Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure India Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure India Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Australia Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Indonesia Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Malaysia Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Philippines Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Thailand Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Vietnam Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Singapore Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Conjugate Vaccines Sales by Product (2014-2019) (K Doses)
Table Asia Pacific Conjugate Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Conjugate Vaccines Market Share by Product
Table Asia Pacific Conjugate Vaccines Sales by End User (2014-2019) (K Doses)
Table Asia Pacific Conjugate Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Conjugate Vaccines Market Share by End User
Figure Central & South America Conjugate Vaccines Sales Growth Rate 2014-2019 (K Doses)
Figure Central & South America Conjugate Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Conjugate Vaccines Sales by Countries (2014-2019) (K Doses)
Table Central & South America Conjugate Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Conjugate Vaccines Sales Market Share by Countries
Table Central & South America Conjugate Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Conjugate Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Conjugate Vaccines Revenue Market Share by Countries
Figure Brazil Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Brazil Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Argentina Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Conjugate Vaccines Sales by Product (2014-2019) (K Doses)
Table Central & South America Conjugate Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Conjugate Vaccines Market Share by Product
Table Central & South America Conjugate Vaccines Sales by End User (2014-2019) (K Doses)
Table Central & South America Conjugate Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Conjugate Vaccines Market Share by End User
Figure Middle East and Africa Conjugate Vaccines Sales Growth Rate 2014-2019 (K Doses)
Figure Middle East and Africa Conjugate Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Conjugate Vaccines Sales by Countries (2014-2019) (K Doses)
Table Middle East and Africa Conjugate Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Conjugate Vaccines Sales Market Share by Countries
Table Middle East and Africa Conjugate Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Conjugate Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Conjugate Vaccines Revenue Market Share by Countries
Figure GCC Countries Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure GCC Countries Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Turkey Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Egypt Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Conjugate Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure South Africa Conjugate Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Conjugate Vaccines Sales by Product (2014-2019) (K Doses)
Table Middle East and Africa Conjugate Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Conjugate Vaccines Market Share by Product
Table Middle East and Africa Conjugate Vaccines Sales by End User (2014-2019) (K Doses)
Table Middle East and Africa Conjugate Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Conjugate Vaccines Market Share by End User
Table Novartis Company Details
Table Novartis Conjugate Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Neuron Biotech Company Details
Table Neuron Biotech Conjugate Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table Neuron Biotech Recent Development
Table Serum Institute of India Company Details
Table Serum Institute of India Conjugate Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table Serum Institute of India Recent Development
Table Pfizer Company Details
Table Pfizer Conjugate Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Conjugate Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table Sanofi Pasteur Recent Development
Table Bharat Biotech Company Details
Table Bharat Biotech Conjugate Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table Bharat Biotech Recent Development
Table Biological Company Details
Table Biological Conjugate Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table Biological Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Conjugate Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Conjugate Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table Merck Recent Development
Table CSL Company Details
Table CSL Conjugate Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table CSL Recent Development
Table Global Conjugate Vaccines Sales Forecast by Regions 2019-2025 (K Doses)
Table Global Conjugate Vaccines Sales Market Share Forecast by Regions 2019-2025
Table Global Conjugate Vaccines Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Conjugate Vaccines Revenue Market Share Forecast by Regions 2019-2025
Table Global Conjugate Vaccines Sales Forecast by Product 2019-2025 (K Doses)
Table Global Conjugate Vaccines Sales Market Share Forecast by Product 2019-2025
Table Global Conjugate Vaccines Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Conjugate Vaccines Revenue Market Share Forecast by Product 2019-2025
Table Global Conjugate Vaccines Sales Forecast by End User 2019-2025 (K Doses)
Table Global Conjugate Vaccines Sales Market Share Forecast by End User 2019-2025
Figure North America Conjugate Vaccines Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure North America Conjugate Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Conjugate Vaccines Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Europe Conjugate Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Conjugate Vaccines Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Asia Pacific Conjugate Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Conjugate Vaccines Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Central & South America Conjugate Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Conjugate Vaccines Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Middle East and Africa Conjugate Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Conjugate Vaccines Value Chain
Table Conjugate Vaccines Customers List
Table Conjugate Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
髄膜炎菌コンジュゲートの世界市場：市場規模・現状・予測 Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meni…- 伴侶動物用ワクチンの世界市場：インサイト・予測 Companion animal vaccines are used to stimulate an immune response in pets such as canine, avian and feline. These vaccine products are of various types such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccine…
- 世界の犬用ワクチン市場：専門的調査 A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Va…
- 世界の猫用ワクチン市場：専門的調査 A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Va…
- 世界の腸チフスワクチン市場：専門的調査 Typhoid fever is contracted by drinking or eating the Salmonella bacteria in contaminated food or water. Typhoid Fever Vaccines prevent typhoid fever and provide protection against it. The global Typhoid Fever Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the …